Literature DB >> 18676203

Cellular responses to MPT-51, GlcB and ESAT-6 among MDR-TB and active tuberculosis patients in Brazil.

João Alves de Araújo-Filho1, Arioldo Carvalho Vasconcelos, Eduardo Martins de Sousa, André Kipnis, Elisângela Ribeiro, Ana Paula Junqueira-Kipnis.   

Abstract

Multi-drug resistant pulmonary tuberculosis (MDR-TB) may result from either insufficiency of the host cellular immune response or mycobacterial mechanisms of resistance. Mycobacterium tuberculosis-specific CD8+ and CD4+ T lymphocytes from MDR-TB patients are poorly studied. The aim of this study was to evaluate CD4+IFN-gamma+, CD4+IL-10+, CD8(+)IFN-gamma+ and CD8+IL-10+ cell populations by flow cytometry in non-resistant TB and multi-drug resistant tuberculosis (MDR-TB) patients from mid-central Brazil after stimulation with MPT-51, GlcB and ESAT-6 recombinant antigens from M. tuberculosis in comparison to tuberculin skin test negative (TST) healthy individuals. Non-resistant TB patients present specific cellular responses (CD4 and CD8, both IFN-gamma and IL-10) to GlcB, MPT-51 and ESAT-6; while MDR-TB patients present only CD8+IFN-gamma+ responses to ESAT-6 and CD8+IL-10+ responses to GlcB and ESAT-6. The results show that MDR-TB patients present impaired specific CD4 IFN-gamma and IL-10 responses and increased/normal specific CD8 IFN-gamma and IL-10 responses. This suggests an important role for CD8 function in these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18676203     DOI: 10.1016/j.tube.2008.06.002

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  9 in total

1.  Decreased expression of perforin in CD8+ T lymphocytes in patients with Mycobacterium tuberculosis infection and its potential value as a marker for efficacy of treatment.

Authors:  Hongbin Jiang; Huili Gong; Qing Zhang; Jin Gu; Li Liang; Jun Zhang
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

Review 2.  Evasion and subversion of antigen presentation by Mycobacterium tuberculosis.

Authors:  A Baena; S A Porcelli
Journal:  Tissue Antigens       Date:  2009-06-25

Review 3.  The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?

Authors:  Anastasia Koch; Valerie Mizrahi; Digby F Warner
Journal:  Emerg Microbes Infect       Date:  2014-03-12       Impact factor: 7.163

4.  Prime-boost with Mycobacterium smegmatis recombinant vaccine improves protection in mice infected with Mycobacterium tuberculosis.

Authors:  Ana Paula Junqueira-Kipnis; Fábio Muniz de Oliveira; Monalisa Martins Trentini; Sangeeta Tiwari; Bing Chen; Danilo Pires Resende; Bruna D S Silva; Mei Chen; Lydia Tesfa; William R Jacobs; André Kipnis
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

5.  A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis.

Authors:  Adeliane Castro da Costa; Abadio de Oliveira Costa-Júnior; Fábio Muniz de Oliveira; Sarah Veloso Nogueira; Joseane Damaceno Rosa; Danilo Pires Resende; André Kipnis; Ana Paula Junqueira-Kipnis
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

6.  Immunogenicity of a fusion protein containing immunodominant epitopes of Ag85C, MPT51, and HspX from Mycobacterium tuberculosis in mice and active TB infection.

Authors:  Eduardo Martins de Sousa; Adeliane Castro da Costa; Monalisa Martins Trentini; João Alves de Araújo Filho; André Kipnis; Ana Paula Junqueira-Kipnis
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

7.  Altered ratio of IFN-γ/IL-10 in patients with drug resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome.

Authors:  Keira H Skolimowska; Molebogeng X Rangaka; Graeme Meintjes; Dominique J Pepper; Ronnett Seldon; Kerryn Matthews; Robert J Wilkinson; Katalin A Wilkinson
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

8.  Cytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis.

Authors:  Valeria Sargentini; Sabrina Mariotti; Stefania Carrara; Maria Cristina Gagliardi; Raffaela Teloni; Delia Goletti; Roberto Nisini
Journal:  BMC Infect Dis       Date:  2009-06-23       Impact factor: 3.090

9.  The use of Mycobacterium tuberculosis HspX and GlcB proteins to identify latent tuberculosis in rheumatoid arthritis patients.

Authors:  Bruna Daniella Souza Silva; Daniela Graner Schuwartz Tannus-Silva; Marcelo Fouad Rabahi; Andre Kipnis; Ana Paula Junqueira-Kipnis
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-02       Impact factor: 2.743

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.